Tests and blood analyses in Bilbao

A selected panel can help review general health, metabolism and risk factors. The exact profile should be adapted to the reason for testing, age and medical history.

A blood draw can combine several determinations in one visit. The team confirms the required tubes, preparation and profiles for the request.

It measures red cells, white cells and platelets and includes an automated five-part white-cell differential. It may be used in general checks, anaemia, infection assessment or pre-operative testing.

It measures metabolic, kidney, liver and other analytes according to the requested panel. Askabide uses dry chemistry for many routine determinations.

It includes the requested lipid fractions to assess cardiovascular risk together with other clinical factors. Fasting requirements depend on the panel and indication.

Glucose reflects the level at the time of sampling, while HbA1c estimates average control over recent months. Both must be interpreted in context and according to the method.

It may combine a full blood count, ferritin, iron and other parameters to help assess the type of anaemia or iron stores. The panel is adapted to the indication.

TSH and other hormones or antibodies are selected according to the reason for testing. Interpretation depends on age, pregnancy, medication and method.

Hormone profiles may include different analytes depending on the menstrual cycle, fertility, menopause, symptoms or follow-up. The day and time of sampling may matter.

Blood β-hCG can confirm and quantify the pregnancy hormone in the appropriate context. A single value does not determine progression on its own and may require follow-up.

It assesses the physical and chemical characteristics of urine and, where indicated, the sediment. Collection quality and time to analysis are important.

It looks for microorganism growth in a correctly collected sample and may include identification and susceptibility testing. It takes longer than a urine dipstick.

The swab and culture required depend on symptoms, site and clinical suspicion. Culture does not replace molecular testing when molecular methods are indicated.

The appropriate test depends on timing, the type of contact and the exposed site. Blood, urine, or genital, rectal or throat swabs may be required.

Molecular testing detects HPV genetic material according to the validated kit and sample. A positive result does not mean cancer and must be interpreted with age, cytology and history.

The test type depends on time since exposure and the indication: combined screening, antibody testing or NAT/PCR in selected situations. A reactive screen requires confirmation.

Molecular tests must use a sample from the exposed site. A negative genital sample does not rule out an untested throat or rectal infection.

Blood serology is selected according to risk, history and time since exposure. Some infections require repeat testing or completion of a confirmation algorithm.

It examines cervical cells and may report categories such as negative, ASC-US, LSIL or HSIL. It is not the same test as molecular HPV detection.

Histopathology describes the tissue and provides a histological diagnosis. Collection, preservation, documentation and referral depend on the procedure.

The required tests depend on the procedure, age, medical history and professional request. They may include a full blood count, coagulation, biochemistry and other tests.

Screening detects groups of substances over a limited window and a presumptive positive may require confirmation. Chain-of-custody requirements must be agreed before collection.

Non-invasive prenatal screening analyses cell-free DNA in maternal blood according to the selected panel. It is screening, not diagnosis, and is coordinated with partner laboratories.

The pathway differs for informational and legally valid testing. Identification, consent and chain of custody must be defined before samples are collected.

They may be useful in selected clinical contexts and follow-up, but they do not diagnose or rule out cancer on their own and are not a universal screening test.

Determinations are selected according to symptoms, diet, medication, pregnancy or follow-up. Not every test is useful as indiscriminate screening.